TTY Biopharm Company Limited appointed Peng,Cheng-Yi as Research and Development Officer. Name, title, and resume of the new position holder: Peng,Cheng-Yi, vice president; Education: The University of Iowa, PharmD; Experience: Sunny Pharmtech Inc, research and development vice president Intech Biopharm, vice president. Effective date is February 01, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
77.1 TWD | -0.26% | +1.58% | -4.10% |
Mar. 14 | TTY Biopharm Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 08 | TTY Biopharm Company Limited Announces Change of CFO and Financial Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.10% | 589M | |
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B |
- Stock Market
- Equities
- 4105 Stock
- News TTY Biopharm Company Limited
- TTY Biopharm Company Limited Appoints Peng,Cheng-Yi as Research and Development Officer, Effective February 01, 2024